Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Atherosclerosis

• A Study of DII235 in Adults With Elevated Lipoprotein(a)
• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
• [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
• A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
• A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity
• Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
• Pelacarsen Roll-over Extension Program
• Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
• Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients
• A Study Evaluating the Stability and Efficacy of IMC-001 for Injection on Atherosclerotic Plaques in Patients With ACS.
• Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
• A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
• ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
• A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.
• Evaluating the Impact of 'Tertinat' on Patients with Atherosclerosis-Related Cardiovascular Diseases
• Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
• Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB
• LATAM LOWERS LDL-C
• The Prevent Coronary Artery Disease Trial
• Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
• A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
• Fish Oil, Metformin and Heart Health in PCOS
• Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular
• Clopidogrel Versus Cilostazol on Vessels
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
• Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
• Specifying the Anti-inflammatory Effects of Ziltivekimab
• VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
• Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease
• Safety and Efficacy of Urinary Kallidinogenase for Large Artery Atherosclerosis Acute Ischemic Stroke
• The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile
• Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
• COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)
• Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
• YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
• Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
• Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
• NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM
• Semaglutide and Vascular Regeneration
• Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• The Effects of Allicor on Patients After Revascularization Treatment During a Year
• Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
• Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
• Fractional Flow Reserve to Determine Atherosclerosis Renal Hypertension Stenting
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
• Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
• Anticoagulant Using Rivaroxaban on Top of Aspirin Versus Antiplatelet Therapy in Intracranial Atherostenosis Stenosis
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
• High-Resolution Assessment of Extracranial Plaques in Evolocumab Treatment
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
• A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356
• Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
• Predicting Stroke Risk in ICAD With Novel MRI
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
• EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
• Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
• Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE)
• A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
• Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
• Colchicine in Decrease of Perivascular Inflammation Index on Coronary CTA: A Randomized Open-label Trial
• A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
• Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
• Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
• Direct Mechanical Thrombectomy Versus Bridging Therapy
• Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
• Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
• A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis
• A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
• Effect Of Semaglutide In Coronary Atheroma Plaque
• 68Ga-FAPI PET/MR for Atherosclerosis
• PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
• A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men
• Trial of PCSK9 Inhibition in Patients With Acute Stroke and Symptomatic Intracranial Atherosclerosis
• A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease
• DES and Medical Treatment for ICAD Trial
• A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTOR
• Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
• Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
• Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
• Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions and Cardiovascular Atherosclerosis.
• Anti-inflammatory Effects of Simvastatin
• Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
• Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles
• Reducing Intracranial atheroSclErosis With Repatha
• Reducing Intracranial atheroSclErosis With Repatha
• PET Detection of CCR2 in Human Atherosclerosis
• A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
• Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)
• Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning
• Oral Colchicine in Argentina to Prevent Restenosis
• Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)
• Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
• Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
• Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
• How Atorvastatin Affects the Gut Flora and Metabolomics?
• Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
• PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis
• Ertugliflozin: Cardioprotective Effects on Epicardial Fat
• Anti-Inflammatory Drug and Endothelial Function
• Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles
• Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody
• A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
• Effect of Atorvastatin on Subclinical Atherosclerosis
• The CHORAL Flow Study
• Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
• 68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis
• Nitrite Effects on Cardiac Muscle in CABG
• How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: A Serial CT Study
• 11C-PIB PET Study in MESA at Columbia University
• Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery
• The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
• Type 2 Diabetic Patients Maintained on Statin Therapy
• Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
• The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
• A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
• Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
• Effect of Evolocumab on Vascular Function
• Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
• SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
• Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
• Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
• Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On
• The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
• Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis
• PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
• Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
• High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
• Coronary Angiography THerapeutic Virtual Reality
• Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis
• High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
• Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis
• Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke.
• High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
• Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.
• Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol
• Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
• Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination
• The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
• Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
• Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease
• IMaging Della PLAcca Carotidea
• Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
• Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
• 18F-Flutemetamol and Plaque Vulnerability
• PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients
• Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
• INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
• Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
• Rosuvastatin Effect on Atherosclerotic Plaque Metabolism
• the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
• Subclinical Cardiovascular Disease in Psoriatic Disease
• P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
• The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
• Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
• Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI
• Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
• RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
• An Extension Trial of Inclisiran Compared to Evolocumab in Participants With Cardiovascular Disease and High Cholesterol
• Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
• Alirocumab and Reverse Cholesterol Transport
• Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
• Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
• Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
• Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
• The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
• Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
• Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
• Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?
• The TRUST Trial - CardioVascular Imaging ECHO
• The TRUST Study - CardioVascular Imaging IMT
• Effect of Statins on Trained Immunity
• Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
• Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
• Coronary Artery Disease Progression in Patients With Prediabetes
• The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
• Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
• Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
• Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
• Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization
• The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
• Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
• Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
• Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
• Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis
• Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
• Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
• Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE
• A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
• Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
• A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
• TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
• Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
• PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)
• CER-001 Atherosclerosis Regression ACS Trial
• Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
• Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
• Effects of Lomitapide on Carotid and Aortic Atherosclerosis
• Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
• Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
• Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
• PET/CT Imaging Companion Study To ACTG A5314
• Pharmacogenomics of Antiplatelet Response
• Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
• Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
• Colchicine in Vascular Inflammation Assessed With PET Imaging
• Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
• Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
• Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
• Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)
• Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.
• Darapladib China PK
• A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.
• Effects Vitamin D Suppletion on Postprandial Leukocyte Activation
• ROsuvastatin LOading and Clinical Outcomes Trial
• Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
• Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDIC
• Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy
• Vitamin D to Improve Endothelial Function in SLE
• Molecular Imaging of Plaque Vulnerability
• Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque
• Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
• Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
• Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).
• Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
• Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
• Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
• The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques
• To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
• A Study to Assess the Effect of SB 659032 on Platelet Function
• SB-659032 Platelet Aggregation Study
• Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
• Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
• Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women
• Atherosclerosis Monitoring and Atherogenicity Reduction Study
• A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
• Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use
• Physical and Chemical Study of Atherosclerosis Mechanisms
• ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
• Fluvastatin AmelIorates aTHerosclerosis Study
• Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
• A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort
• Revacept in Symptomatic Carotid Stenosis
• Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
• Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease
• Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis
• Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism
• Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
• Saxagliptin and Atherosclerosis
• Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells
• Effect of Aged Garlic Extract on Atherosclerosis
• Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration
• Aliskiren Effect on Aortic Plaque Progression
• The Effect of Vitamin A on Atherosclerosis
• Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
• Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
• Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
• Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
• Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
• A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
• Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
• REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
• Type 2 Diabetes Mellitus and Atherosclerosis
• The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
• Comprehensive Evaluation of Ischemic Heart Disease Using MRI
• Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
• Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function
• Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis
• Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
• Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
• Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
• A Trial of Rosuvastatin in Systemic Lupus Erythematosus
• Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries
• Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid
• A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
• Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
• Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
• Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
• Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
• Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)
• Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
• Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
• The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis
• Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
• Ramipril 10 mg/Day Prevention
• AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
• Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
• A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
• Statin Therapy to Improve Atherosclerosis in HIV Patients
• The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis
• Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
• Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
• Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
• Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
• Resistance to Antithrombotic Therapy
• Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
• A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
• Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?
• Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects
• Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
• Local Paclitaxel Delivery for SFA Disease
• Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
• Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
• Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
• Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements
• The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
• Persantin Preceding Elective PCI
• Platelet Hyperreactivity to Aspirin and Stroke
• Inflammation and Vascular Function in Atherosclerosis
• Inflammation and Vascular Function in Atherosclerosis
• A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848
• Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
• A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
• Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
• Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
• Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
• Anti-Inflammatory Effects of Pioglitazone
• Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
• Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
• Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
• A Study With Darapladib to Collect Tolerability Information
• Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
• Change in Plaque Characteristics With Atorvastatin
• An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
• Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
• Effects of Crestor on Inflammation of Atherosclerotic Plaques
• Intravenous Versus Intracoronary Use of Abciximab
• Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
• Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation
• Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
• The Copenhagen Insulin and Metformin Therapy Trial
• Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
• Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
• Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
• Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)
• Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)
• Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)
• Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
• Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)
• Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
• Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
• A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
• Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-
• CRESTOR Athero Imaging Head to Head IVUS Study
• Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
• Vascular Endothelial Protection Effects of Dextromethorphan
• Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
• Evaluation of Atorvastatin on Atherosclerosis Composition
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
• Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
• Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
• A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men
• A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
• 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
• A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
• Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
• Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
• Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
• The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients
• Comparison Of Two Tablet Formulations Of SB-568859
• Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism
• Effect of 5 Years of GH Replacement on Atherosclerosis
• Imaging of Totally Blocked Arteries
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
• PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• The Effect of Licorice Root Extract and Pomegranate Juice on Atherosclerotic Parameters in Diabetic Patients
• The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
• Rilonacept to Improve Artery Function in Patients With Atherosclerosis
• Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart
• Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
• Effect Of Rilapladib (SB-659032) On Platelet Aggregation
• Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
• A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
• PIoglitazone for PrEvention of Restenosis in Diabetic Patients
• Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus
• Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
• Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
• A Study To Determine The Effect Of SB-480848 On Asthma
• Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
• Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
• Intensive Glycemic Control and Skeletal Health Study
• Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
• Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
• Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
• Testosterone Replacement in Older Men and Atherosclerosis Progression
• Aspirin Dose and Atherosclerosis in Patients With Heart Disease
• Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
• SB-480848 In Subjects With Coronary Heart Disease
• Integrated Biomarker And Imaging Study - 2
• The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
• Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
• Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
• Serp-1 for the Treatment of Acute Coronary Syndrome
• Reducing Total Cardiovascular Risk in an Urban Community
• Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
• Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
• Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant
• Aspirin for the Prevention of Recurrent Venous Thromboembolism
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
• Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
• Effect of Valsartan on Carotid Artery Disease
• Olmesartan Medoxomil in Atherosclerosis
• Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
• Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
• The Impact of Rosiglitazone on Regression of Atherosclerosis
• EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
• Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.
• High-Density Lipoprotein (HDL) Modulation and Endothelial Function
• Stop Atherosclerosis in Native Diabetics Study
• Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
• The Study of Atherosclerosis With Ramipril and Rosiglitazone
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
• Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
• High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
• STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
• Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
• Lupus Atherosclerosis Prevention Study
• The Effect of Fasudil on Vascular Function in Humans
• Niacin Plus Statin to Prevent Vascular Events
• Tea's Effect on Atherosclerosis Pilot Study (TEA Study)
• MARS - Monitored Atherosclerosis Regression Study
• Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
• TART - Troglitazone Atherosclerosis Regression Trial
• Rho Kinase in Patients With Atherosclerosis
• The Effects of Atorvastatin in Patients With Atherosclerosis
• The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
• EPAT: Estrogen in the Prevention of Atherosclerosis Trial
• ELITE: Early Versus Late Intervention Trial With Estradiol
• Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation
• Rosuvastatin Affecting Aortic Valve Endothelium
• BVAIT: B-Vitamin Atherosclerosis Intervention Trial
• VEAPS: Vitamin E Atherosclerosis Prevention Study
• Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
• Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
• ARISE - Aggressive Reduction of Inflammation Stops Events
• Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
• A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
• Stop Atherosclerosis in Native Diabetics Study
• Effect of High Dose Vitamin E on Carotid Atherosclerosis
• Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
• Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
• Aspirin Or Warfarin To Prevent Stroke
• Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
• The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
• The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• Familial Atherosclerosis Treatment Study
• Cholesterol Reduction in Seniors Program (CRISP)